Literature DB >> 11588398

Case-control studies of genetic markers: power and sample size approximations for Armitage's test for trend.

S L Slager1, D J Schaid.   

Abstract

The association of a candidate gene with disease can be efficiently evaluated by a case-control study in which allele frequencies are compared for diseased cases and unaffected controls. However, when the distribution of genotypes in the population deviates from Hardy-Weinberg proportions, the frequency of genotypes--rather than alleles--should be compared by the Armitage test for trend. We present formulas for power and sample size for studies that use Armitage's trend test. The formulas make no assumptions about Hardy-Weinberg equilibrium, but do assume random ascertainment of cases and controls, all of whom are independent of one another. We demonstrate the accuracy of the formulas by simulations. Copyright 2001 S. Karger AG, Basel

Mesh:

Substances:

Year:  2001        PMID: 11588398     DOI: 10.1159/000053370

Source DB:  PubMed          Journal:  Hum Hered        ISSN: 0001-5652            Impact factor:   0.444


  38 in total

1.  A robust method for testing association in genome-wide association studies.

Authors:  Zhongxue Chen; Hon Keung Tony Ng
Journal:  Hum Hered       Date:  2011-12-30       Impact factor: 0.444

2.  Nonparametric tests of association of multiple genes with human disease.

Authors:  Daniel J Schaid; Shannon K McDonnell; Scott J Hebbring; Julie M Cunningham; Stephen N Thibodeau
Journal:  Am J Hum Genet       Date:  2005-03-22       Impact factor: 11.025

3.  A constrained-likelihood approach to marker-trait association studies.

Authors:  Kai Wang; Val C Sheffield
Journal:  Am J Hum Genet       Date:  2005-09-14       Impact factor: 11.025

4.  Genetic model selection in two-phase analysis for case-control association studies.

Authors:  Gang Zheng; Hon Keung Tony Ng
Journal:  Biostatistics       Date:  2007-11-13       Impact factor: 5.899

5.  Incorporating duplicate genotype data into linear trend tests of genetic association: methods and cost-effectiveness.

Authors:  Bryce Borchers; Marshall Brown; Brian McLellan; Airat Bekmetjev; Nathan L Tintle
Journal:  Stat Appl Genet Mol Biol       Date:  2009-05-05

6.  Where is the causal variant? On the advantage of the family design over the case-control design in genetic association studies.

Authors:  Claire Dandine-Roulland; Hervé Perdry
Journal:  Eur J Hum Genet       Date:  2015-01-14       Impact factor: 4.246

7.  An Analytic Solution to the Computation of Power and Sample Size for Genetic Association Studies under a Pleiotropic Mode of Inheritance.

Authors:  Derek Gordon; Douglas Londono; Payal Patel; Wonkuk Kim; Stephen J Finch; Gary A Heiman
Journal:  Hum Hered       Date:  2017-03-18       Impact factor: 0.444

8.  Detecting and exploiting etiologic heterogeneity in epidemiologic studies.

Authors:  Colin B Begg; Emily C Zabor
Journal:  Am J Epidemiol       Date:  2012-08-24       Impact factor: 4.897

9.  PCA-based bootstrap confidence interval tests for gene-disease association involving multiple SNPs.

Authors:  Qianqian Peng; Jinghua Zhao; Fuzhong Xue
Journal:  BMC Genet       Date:  2010-01-26       Impact factor: 2.797

10.  Concordant association of insulin degrading enzyme gene (IDE) variants with IDE mRNA, Abeta, and Alzheimer's disease.

Authors:  Minerva M Carrasquillo; Olivia Belbin; Fanggeng Zou; Mariet Allen; Nilufer Ertekin-Taner; Morad Ansari; Samantha L Wilcox; Mariah R Kashino; Li Ma; Linda H Younkin; Samuel G Younkin; Curtis S Younkin; Toros A Dincman; Melissa E Howard; Chanley C Howell; Chloe M Stanton; Christopher M Watson; Michael Crump; Veronique Vitart; Caroline Hayward; Nicholas D Hastie; Igor Rudan; Harry Campbell; Ozren Polasek; Kristelle Brown; Peter Passmore; David Craig; Bernadette McGuinness; Stephen Todd; Patrick G Kehoe; David M Mann; A David Smith; Helen Beaumont; Donald Warden; Clive Holmes; Reinhard Heun; Heike Kölsch; Noor Kalsheker; V Shane Pankratz; Dennis W Dickson; Neill R Graff-Radford; Ronald C Petersen; Alan F Wright; Steven G Younkin; Kevin Morgan
Journal:  PLoS One       Date:  2010-01-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.